Episode 9 of Optimum Perspectives Podcast features Optimum's Richard Staines and Eva Haas, who discuss the hot areas for investment in the shifting biotech market – including antibody-drug conjugates, smart radiotherapies, mRNA and immune-oncology. Want us to explore a topic further? Let us know!
Hosted on Acast. See acast.com/privacy for more information.
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More